[
  {
    "ts": "2025-11-11T00:00:00+00:00",
    "headline": "Eli Lilly cuts surprising deals with upstart biotech players",
    "summary": "Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated deal with the White House. The move underlines Eli Lilly’s ambition to expand beyond its dominant ...",
    "url": "https://www.thestreet.com/investing/stocks/eli-lilly-cuts-surprising-deals-with-upstart-biotech-players",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "3af520e7-cb4a-3151-a9fd-c264d4c52b6f",
      "content": {
        "id": "3af520e7-cb4a-3151-a9fd-c264d4c52b6f",
        "contentType": "STORY",
        "title": "Eli Lilly cuts surprising deals with upstart biotech players",
        "description": "",
        "summary": "Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two strategic deals, following the highly anticipated deal with the White House. The move underlines Eli Lilly’s ambition to expand beyond its dominant ...",
        "pubDate": "2025-11-11T00:00:00Z",
        "displayTime": "2025-11-11T00:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z0L6ukO6JGXpAK26OgNTjA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d3v49gU8yXup7hM9Rr7aaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/57caa2ddd6451258ff2dbf63f7196090.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/investing/stocks/eli-lilly-cuts-surprising-deals-with-upstart-biotech-players",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-cuts-surprising-deals-000000281.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T09:25:00+00:00",
    "headline": "Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?",
    "summary": "Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.",
    "url": "https://www.fool.com/investing/2025/11/11/win-intense-battle-rule-glp-1-drug-lly-nvo-pfe/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "7600dc29-a7f0-397a-8c3c-7b2508f19c52",
      "content": {
        "id": "7600dc29-a7f0-397a-8c3c-7b2508f19c52",
        "contentType": "STORY",
        "title": "Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?",
        "description": "",
        "summary": "Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.",
        "pubDate": "2025-11-11T09:25:00Z",
        "displayTime": "2025-11-11T09:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A package of a weight-loss drug next to a barbell.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uy.JmKH8mGx7AIwWfdl7XA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A1zrw5Cb3qAMPzn97Rm55w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0f189b86e73e67f4cf765d58dbf57476.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/11/win-intense-battle-rule-glp-1-drug-lly-nvo-pfe/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/whos-winning-intense-battle-rule-092500402.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T10:30:00+00:00",
    "headline": "Obesity Drugs Are About to Go Mass-Market",
    "summary": "For most of Big Pharma, drug discounts have largely been about damage control.  After months of tariff threats and talk of tougher pricing rules that weighed on their shares, several chief executives have made their way to the White House to announce drug-pricing deals in exchange for regulatory relief.  For  Eli Lilly’s    David Ricks  and  Novo Nordisk’s    Mike Doustdar,  who paid their own visit to the White House last week, the calculus is different.",
    "url": "https://www.wsj.com/health/pharma/ozempic-glp1-weight-loss-mass-market-f70f8484?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b2aa9d81-f8af-30ce-a574-a07b350656b9",
      "content": {
        "id": "b2aa9d81-f8af-30ce-a574-a07b350656b9",
        "contentType": "STORY",
        "title": "Obesity Drugs Are About to Go Mass-Market",
        "description": "",
        "summary": "For most of Big Pharma, drug discounts have largely been about damage control.  After months of tariff threats and talk of tougher pricing rules that weighed on their shares, several chief executives have made their way to the White House to announce drug-pricing deals in exchange for regulatory relief.  For  Eli Lilly’s    David Ricks  and  Novo Nordisk’s    Mike Doustdar,  who paid their own visit to the White House last week, the calculus is different.",
        "pubDate": "2025-11-11T10:30:00Z",
        "displayTime": "2025-11-11T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b2aa9d81-f8af-30ce-a574-a07b350656b9/obesity-drugs-are-about-to-go.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r3EYtfWi7DUenDdrNOIVjQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T5qoowdQPCQB7Wmdu4lvWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/ozempic-glp1-weight-loss-mass-market-f70f8484?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T04:37:55+00:00",
    "headline": "2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds",
    "summary": "Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.",
    "url": "https://finance.yahoo.com/news/2-volatile-stocks-impressive-fundamentals-043755591.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "7514dfe8-b5a9-34f9-be81-a13ba33c55c9",
      "content": {
        "id": "7514dfe8-b5a9-34f9-be81-a13ba33c55c9",
        "contentType": "STORY",
        "title": "2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds",
        "description": "",
        "summary": "Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.",
        "pubDate": "2025-11-11T04:37:55Z",
        "displayTime": "2025-11-11T04:37:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0853feacc1714816055c5fd627257ffb",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "COIN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JPzvkxTm6sZVUu6VjgxGQw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0853feacc1714816055c5fd627257ffb.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d2yqxW.HvCKxREHWmQROmg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0853feacc1714816055c5fd627257ffb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-volatile-stocks-impressive-fundamentals-043755591.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-volatile-stocks-impressive-fundamentals-043755591.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELAN"
            },
            {
              "symbol": "COIN"
            },
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T13:52:00+00:00",
    "headline": "Trifecta Health and Trifecta Med Spa Announce Strategic Cooperation to Enhance Patient Access to Weight Loss Treatments",
    "summary": "Trifecta Health and Trifecta Med Spa are excited to announce two strategic cooperations aimed at improving patient access to high-quality obesity treatments. These cooperations will streamline the process for patients to receive FDA-approved medications directly from the manufacturers at the most affordable prices.",
    "url": "https://finance.yahoo.com/news/trifecta-health-trifecta-med-spa-135200758.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "320a1c91-124f-3ac6-a378-c3b4408366ed",
      "content": {
        "id": "320a1c91-124f-3ac6-a378-c3b4408366ed",
        "contentType": "STORY",
        "title": "Trifecta Health and Trifecta Med Spa Announce Strategic Cooperation to Enhance Patient Access to Weight Loss Treatments",
        "description": "",
        "summary": "Trifecta Health and Trifecta Med Spa are excited to announce two strategic cooperations aimed at improving patient access to high-quality obesity treatments. These cooperations will streamline the process for patients to receive FDA-approved medications directly from the manufacturers at the most affordable prices.",
        "pubDate": "2025-11-11T13:52:00Z",
        "displayTime": "2025-11-11T13:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/0ef6da2f95469a4c5c9661c95ec8fb2d",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bm294OC8_9xU88T7zaRClQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ef6da2f95469a4c5c9661c95ec8fb2d.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Rwhy1yA9h0wgXbURMQ.zkg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ef6da2f95469a4c5c9661c95ec8fb2d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trifecta-health-trifecta-med-spa-135200758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trifecta-health-trifecta-med-spa-135200758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]